Skip to content
2000
Volume 1, Issue 2
  • ISSN: 2211-5528
  • E-ISSN:

Abstract

Radiation, chemotherapy, and surgery share roles in modern cancer therapy targeting neoplastic tumor cells. Greater understanding of the importance of angiogenesis and tumor neovascularization in oncology has led to development of another therapeutic modality, angiogenesis inhibitors, which specifically target the tumor vasculature. Antiangiogenic agents have been shown to act synergistically with traditional cytotoxic treatments, including radiation, against a variety of tumor histologies. Their selective incorporation in multimodality therapy based on tumor type, angiogenic profile, and individual patient response offers the potential for greater disease control. In this review we summarize studies evaluating angiogenesis inhibitors combined with radiation in cancer therapy, and progress made towards optimally incorporating these agents into established treatment regimens.

Loading

Article metrics loading...

/content/journals/cag/10.2174/2211552811201020157
2012-06-01
2024-11-26
Loading full text...

Full text loading...

/content/journals/cag/10.2174/2211552811201020157
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test